Literature DB >> 11901906

Staging classification of lung cancer. A critical evaluation.

Clifton F Mountain1.   

Abstract

The International System for Staging Lung Cancer has been validated as a prognostic index and questioned regarding the implications of factors that require further study. As technology for evaluating the anatomic extent of disease is increasingly refined, the accuracy of clinical staging is greatly improved and provides a major benefit for individualized treatment selection. Advancing knowledge of the origin and development of lung tumors presents the challenge of appropriate integration of this body of science into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901906     DOI: 10.1016/s0272-5231(03)00063-7

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  19 in total

1.  Segmentation of the central-chest lymph nodes in 3D MDCT images.

Authors:  Kongkuo Lu; William E Higgins
Journal:  Comput Biol Med       Date:  2011-07-12       Impact factor: 4.589

2.  Prognostic gene signatures for non-small-cell lung cancer.

Authors:  Paul C Boutros; Suzanne K Lau; Melania Pintilie; Ni Liu; Frances A Shepherd; Sandy D Der; Ming-Sound Tsao; Linda Z Penn; Igor Jurisica
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

3.  Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer.

Authors:  James B Yu; Pamela R Soulos; Laura D Cramer; Roy H Decker; Anthony W Kim; Cary P Gross
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

4.  Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies.

Authors:  Rafael Molina; Elias Alvarez; Angeles Aniel-Quiroga; Maria Borque; Belen Candás; Antonio Leon; Rafael M Poyatos; Montserrat Gelabert
Journal:  Tumour Biol       Date:  2010-08-21

5.  Automatic definition of the central-chest lymph-node stations.

Authors:  Kongkuo Lu; Pinyo Taeprasartsit; Rebecca Bascom; Rickhesvar P M Mahraj; William E Higgins
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-02-27       Impact factor: 2.924

6.  Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.

Authors:  Robert S Stearman; Lori Dwyer-Nield; Laura Zerbe; Stacy A Blaine; Zeng Chan; Paul A Bunn; Gary L Johnson; Fred R Hirsch; Daniel T Merrick; Wilbur A Franklin; Anna E Baron; Robert L Keith; Raphael A Nemenoff; Alvin M Malkinson; Mark W Geraci
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

7.  Thoracic cavity definition for 3D PET/CT analysis and visualization.

Authors:  Ronnarit Cheirsilp; Rebecca Bascom; Thomas W Allen; William E Higgins
Journal:  Comput Biol Med       Date:  2015-04-23       Impact factor: 4.589

Review 8.  Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer.

Authors:  Kosei Yasumoto; Takeshi Hanagiri; Mitsuhiro Takenoyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-09-13

9.  Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis.

Authors:  Zhaofei Pang; Yufan Yang; Nan Ding; Cuicui Huang; Tiehong Zhang; Yang Ni; Jiajun Du; Qi Liu
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

10.  High-risk-pattern lung adenocarcinoma with epidermal growth factor receptor mutation is associated with distant metastasis risk and may benefit from adjuvant targeted therapy.

Authors:  Liang Wang; Xing Wang; Miao Huang; Shi Yan; Shaolei Li; Chao Lv; Nan Wu; Yue Yang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.